Tsang-Chih Kuo

Tsang-Chih Kuo has worked in various roles in the biotechnology industry since 2013. Tsang-Chih began their career at National Taiwan University, where they were a postdoctoral research fellow at the School of Medicine's Toxicology Research Institute and the College of Life Science's Department of Biochemistry. From 2017 to 2021, they worked at TFBS Bioscience, Inc., where they held positions as Senior Manager of the Manufacturing Department, Manager of the Manufacturing Department, and Scientist in the CEO office. In 2021, they joined Porton Advanced Cell & Gene Therapy CDMO as Assistant Director of the Project Management Department and Senior Manager of the Project Management Department. Tsang-Chih currently holds the role of Director of the CMC Department at NeuExcell Therapeutics.

Tsang-Chih Kuo attended National Taiwan University from 2007 to 2013, earning a Doctorate in Toxicology from the School of Medicine. Prior to this, they attended Chung Shan Medical University from 2002 to 2006, where they earned a Bachelor's degree in Biological Sciences.